Publications‎ > ‎

From year (2011 - 2015)

  • Hamdy A. Azim and Hatem A. Azim Jr. Potential Therapeutic Targets in Triple Negative Breast Cancer. Current Breast Cancer Rep. First online: 23 September 2015. DOI 10.1007/s12609-015-0192-1

  • HUSSEIN KHALED, HAMDY ABDEL AZIM, EMAD BARSOUM, GEORGE CHAHINE, ALI SHAMSEDDINE, GAMAL ABDEL METAAL, ABBAS OMAR, ABDUL RAHMAN JAZEIH, RASHA HAGGAG and ATEF BADRAN.A multicenter, phase II study of the RAF-kinase inhibitor sorafenib in patients with advanced renal cell carcinoma.  MOLECULAR AND CLINICAL ONCOLOGY 3: 1099-1102, 2015

  • Hamdy Abdel Azim, Yasse Abdal-Kader, Mohamed  Mousa, Raafat Abdel Male, Michael Abdalmassih, Noha Ibrahim . Taxane-Based Regimens as Adjuvant Treatment for Breast Cancer: a Retrospective Study in Egyptian Cancer Patients. Asian Pac J Cancer Prev, 2015 ;16(1):65-9
    Neemat M. Kassem , Hamdy EL Zawam , Heba A. Kassem ,Tamer EL Nahas , Noha M. El Husseiny , Hamdy Abdel Azim. A descriptive study of plasma cell dyscrasias in Egyptian population. Journal of the Egyptian National Cancer Institute 2014 ; 26, 67–71

  • KASSEM NEEMAT, KHALIFA RANIA, MOHAMED TAREK, HAMDY  ABDEL AZIM. Effect of 13q Deletion on IL-6 Production in Patients with Multiple Myeloma: A Hypothesis May Hold True. Clin. Lab. 2014;60:1393-1399

  • Hamdy A Azim , Raafat A Malek and  Hatem A Azim Jr.  Clinico-pathological features and 5-year disease free survival of invasive lobular carcinoma in Egyptian women .WOMEN  HEALTH  2014; 10(5), 511–518

  • Azim HA, Ibrahim AS. Breast cancer in Egypt, China and Chinese: statistics and beyond. J Thorac Dis 2014 June . doi: 10.3978/j.issn.2072-1439.2014.06.38

  • Tamara Rordorf , Azza Adel Hassan , Hamdy Azim , Eniu Alexandru , Ozlem Er , Erhan Gokmen , Zeynep Güral , Jozef Mardiak , Velko Minchev , Florentia Peintinger , Miklos Szendroi , Itzok Takac , Petra Tesarova , Daniel Vorobiof , Damir Vrbanec , Ramazan Yildiz , Serap Yücel , Jamal Zekri , Basak Oyan. Bone Health in Breast Cancer Patients: A Comprehensive Statement by CECOG/SAKK Intergroup THE BREAST-D-13-533R1, 2014

  • Azim HA,and Saadeldeen A. Commentary on “aTTom”: long-term effects of continuing adjuvant Tamoxifen to 10 years. Chin Clin Oncol 2014

  • Hamdy A Azim, Sherif Bahr, Nermine  Kamal et al . One for the road! A study to assess the efficacy of single low-dose regimen of rasburicase in controlling hyperuricaemia in patients with tumour lysis syndrome due to haematological malignancies. ecancer 2013, 7:378 DOI: 10.3332

  • Hatem A Azim Jr &Hamdy A Azim: Breast cancer arising at a young age: Do we need to define a cut-off? The Breast  22, 1007–1008, 2013

  • Azim HA, Kamal NS, Malak RA. Bisphosphonates in the adjuvant treatment of young women with breast cancer: the estrogen rich is a poor candidate! J Thorac Dis. 2013;5:S27-S35.

  • Azim H, Azim HA Jr. Targeting RANKL in breast cancer: bone metastasis and beyond. Expert Rev Anticancer Ther. 2013;13:195-201.

  • Raafat Abdel Malek, Ghada Zakaria, Omar Abdelrhman, Hamdy Abdel Azim. Earlier breast cancer diagnosis in Egyptian women with positive family history. Pan Arab Journal of Oncology, vol 6; issue 1, March 2013

  • -Hamdy A Azim & Hatem A Azim Jr : Systemic treatment of brain  metastases in HER2-positive breast cancer: current status and future directions,Future Oncol. (2012) 8(2), 135–144
  • -Nabil Mubarak, Rabab Gaafar, Samir Shehata, Tarek Hashem, Dani Abigeres, Hamdy A Azim ,Gamal El-Husseiny, Hamed Al-Husaini and Zhixin Liu :A randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous non-small cell lung cancer BMC Cancer 2012, 12:423
  • -Hamdy A. Azim , Nermine S. Kamal , Hatem A. Azim Jr. Bone metastasis in breast cancer: The story of RANK-Ligand Journal of the Egyptian National Cancer Institute2012 Aug ;43 :1-9
  • -Nagi S. El Saghir , Nadine El-Asmar , Carla Hajj , Toufic Eid , Sami Khatib , Adda Bounedjar ,Dahish Ajarim , Ali Shamseddine , Fady Geara , Abdelrahman Jazieh , Hamdy A. Azim , Yasser Abdelkader , Joseph Kattan , Omalkhair Abulkha :Survey of utilization of multidisciplinary management tumor boards in Arab countries. The Breast 20 (2011) S70-S74
  • Naeemt Kassem Novel mutations of nucleoplasmin (NPM-1) gene in Egyptian patients with Acute myeloid leukemia; a pilot study. et al; Journal of the Egyptian NCI (2011) 23, 73-78.

  • Azim HA, Bahr SA, Koura MA, Gad H, Farouk M, Morsy A, Iskander I, Hammad A, Fat'hy M, Attia H, Sadek K. Case Study in Refractory Non-Hodgkin's Lymphoma: Successful Treatment with Plerixafor. Case Rep Oncol. 2011 Sep;4(3):467-9.

Ċ
NEMROCK Publications (10-Sep-13).pdf
(145k)
Hanan Selim Musalm Darwish,
Feb 18, 2020, 8:10 AM
v.1
Comments